Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
IntroductionMonkeypox is a zoonotic disease caused by brick-shaped enveloped monkeypox (Mpox) virus that belongs to the family of ancient viruses known as Poxviridae. Subsequently, the viruses have been reported in various countries. The virus is transmitted by respiratory droplets, skin lesions, an...
Main Authors: | Amar Ajmal, Arif Mahmood, Chandni Hayat, Mohammed Ageeli Hakami, Bader S. Alotaibi, Muhammad Umair, Ashraf N. Abdalla, Ping Li, Pei He, Abdul Wadood, Junjian Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1159389/full |
Similar Items
-
New drug target identification in Vibrio vulnificus by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulations
by: Bader S. Alotaibi, et al.
Published: (2023-07-01) -
In silico repurposed drugs against monkeypox virus
by: Lam, Hilbert Yuen In, et al.
Published: (2023) -
In Silico Repurposed Drugs against Monkeypox Virus
by: Hilbert Yuen In Lam, et al.
Published: (2022-08-01) -
Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study
by: Thua-Phong Lam, et al.
Published: (2022-09-01) -
Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
by: Andrea Dodaro, et al.
Published: (2023-04-01)